Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Childhood asthma link shows it is never too soon for mums to quit smoking

Smoking during pregnancy increases the risk for asthma and wheezing in early childhood, even if children are not exposed to smoke after birth, a European study shows.

21 Aug 2012

Healthy brown-bag lunch can combat obesity in school children

As the new school year approaches, parents have to decide what their children will eat for lunch. Should they help the kids brown bag it or remember to take their lunch money? While this might not seem to be a major issue, it is - because the importance of school lunch rises with the rates of childhood obesity, say University of Alabama at Birmingham experts.

21 Aug 2012

Allergy transmission may be gender specific

Parents with allergies are more likely to pass them on to their same gender children than to children of the opposite gender, say researchers.

17 Aug 2012

Mepolizumab almost halves exacerbations in severe asthma patients

The largest study of patients with severe asthma to date, published in The Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50% reduction in severe exacerbations, emergency room visits, and hospitalisations compared with patients given placebo.

17 Aug 2012

Retail medical clinic visits increase four-fold from 2007-2009

Fast-growing retail medical clinics are attracting more older patients and delivering more preventive care, particularly flu shots and other vaccinations, according to a new study from the RAND Corporation.

17 Aug 2012

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Virginia Commonwealth University and Nostrum Pharmaceuticals, LLC, are pleased to announce the signing of a license agreement for the development of inhaled dapsone for the treatment of respiratory diseases.

17 Aug 2012

Smoking during pregnancy associated with wheezing and asthma in preschool children

Maternal smoking during pregnancy is associated with wheeze and asthma in preschool children, even among children who were not exposed to maternal smoking late in pregnancy or after birth, according to a new study.

17 Aug 2012

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever, showed significant improvement in respiratory disturbance and adenoid size, according to a new study published in Pediatrics Journal.

17 Aug 2012

Malignant mesothelioma diagnosis with an E-nose: an interview with Associate Professor Deborah Yates, UNSW

Malignant mesothelioma is a rare tumor of the pleura which is the lining of the inside of the chest wall. It is highly linked with asbestos exposure.

16 Aug 2012

CD4 T cells orchestrate inflammatory attack on the artery wall

Most people probably know that heart disease remains the nation's No. 1 killer. But what many may be surprised to learn is that cholesterol has a major accomplice in causing dangerous arterial plaque buildup that can trigger a heart attack. The culprit? Inflammatory cells produced by the immune system.

15 Aug 2012

FDA approves Intelliject's Auvi-Q for anaphylaxis

Intelliject, Inc. announced that the U.S. Food and Drug Administration approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk or have a history of anaphylaxis. This is the first-and-only compact auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection process.

13 Aug 2012

Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis

Meritage Pharma, Inc. announced that it has initiated a Phase 2 clinical trial to evaluate oral budesonide suspension (OBS) for the treatment of adolescents and young adults with eosinophilic esophagitis (EoE), an allergic inflammatory condition of the esophagus. EoE is a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation.

13 Aug 2012

New report examines detrimental impact of building materials and products on asthma

Leading global interdisciplinary design firm Perkins+Will today released a new report examining the detrimental impact of building materials and products on asthma.

9 Aug 2012

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012

Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.

7 Aug 2012

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.

6 Aug 2012

Common ragweed may induce airways irritation through terpenoids

Allergy to pollen of common ragweed is increasingly affecting patients and is second only to grass pollen in terms of incidence in the general population of many European countries.

6 Aug 2012

TAU research identifies protein group that may kick-start allergic reactions

Allergies, or hypersensitivities of the immune system, are more common than ever before. According to the Asthma and Allergies Foundation of America, one in five Americans suffers from an allergy - from milder forms like hay fever to more severe instances, like peanut allergies which can lead to anaphylactic shock.

6 Aug 2012

First generic versions of Singulair receive FDA approval for treatment of asthma, allergies

The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.

6 Aug 2012

Exposure to mold during infancy linked to asthma development during childhood

In the United States, one in 10 children suffers from asthma but the potential environmental factors contributing to the disease are not well known. Cincinnati-based researchers now report new evidence that exposure to three types of mold during infancy may have a direct link to asthma development during childhood.

3 Aug 2012

Asthma News and Research

Further Reading

Childhood asthma link shows it is never too soon for mums to quit smoking

Healthy brown-bag lunch can combat obesity in school children

Allergy transmission may be gender specific

Mepolizumab almost halves exacerbations in severe asthma patients

Retail medical clinic visits increase four-fold from 2007-2009

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Smoking during pregnancy associated with wheezing and asthma in preschool children

Montelukast improves respiratory disturbance and adenoid size in children with OSA

Malignant mesothelioma diagnosis with an E-nose: an interview with Associate Professor Deborah Yates, UNSW

CD4 T cells orchestrate inflammatory attack on the artery wall

FDA approves Intelliject's Auvi-Q for anaphylaxis

Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis

New report examines detrimental impact of building materials and products on asthma

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Common ragweed may induce airways irritation through terpenoids

TAU research identifies protein group that may kick-start allergic reactions

First generic versions of Singulair receive FDA approval for treatment of asthma, allergies

Exposure to mold during infancy linked to asthma development during childhood

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News